{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:29:34Z","timestamp":1789097374668,"version":"build-2803163510"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.cellsig.2025.111956","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T02:42:24Z","timestamp":1750387344000},"page":"111956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Therapeutic potential of ghrelin and synthetic GHS for heart failure from the perspective of its protective effect on cardiomyocytes"],"prefix":"10.1016","volume":"134","author":[{"given":"Qiang","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cellsig.2025.111956_bb0005","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12020-015-0531-z","article-title":"Implications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases","volume":"49","author":"Mosa","year":"2015","journal-title":"Endocrine"},{"issue":"6762","key":"10.1016\/j.cellsig.2025.111956_bb0010","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111956_bb0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1385\/ENDO:15:1:029","article-title":"Growth hormone-releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults","volume":"15","author":"Ghigo","year":"2001","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.cellsig.2025.111956_bb0020","first-page":"1186","article-title":"Growth hormone (GH) releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation","volume":"83","author":"Pandya","year":"1998","journal-title":"J. Clin. Endocr. Metab."},{"issue":"18","key":"10.1016\/j.cellsig.2025.111956_bb0025","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/0024-3205(94)00510-9","article-title":"Gh-releasing activity of hexarelin, a new growth-hormone releasing peptide, in infant and adult-rats","volume":"54","author":"Deghenghi","year":"1994","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111956_bb0030","first-page":"253","article-title":"The cardiovascular action of hexarelin","volume":"11","author":"Mao","year":"2014","journal-title":"J. Geriatr. Cardiol."},{"issue":"24","key":"10.1016\/j.cellsig.2025.111956_bb0035","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1161\/01.CIR.0000149746.62908.BB","article-title":"Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure","volume":"110","author":"Nagaya","year":"2004","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cellsig.2025.111956_bb0040","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.transproceed.2022.08.028","article-title":"Ghrelin may inhibit inflammatory response and apoptosis during ischemia-reperfusion injury","volume":"54","author":"Fukunaga","year":"2022","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.cellsig.2025.111956_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110165","article-title":"Hexarelin targets neuroinflammatory pathways to preserve cardiac morphology and function in a mouse model of myocardial ischemia- reperfusion","volume":"127","author":"McDonald","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111956_bb0050","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200634R","article-title":"Potential role of ghrelin in the regulation of inflammation","volume":"36","author":"Ma","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.cellsig.2025.111956_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.peptides.2014.09.015","article-title":"Effect of ghrelin on autonomic activity in healthy volunteers","volume":"62","author":"Soeki","year":"2014","journal-title":"Peptides"},{"issue":"12","key":"10.1016\/j.cellsig.2025.111956_bb0060","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.peptides.2009.09.004","article-title":"Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect","volume":"30","author":"Huang","year":"2009","journal-title":"Peptides"},{"issue":"7","key":"10.1016\/j.cellsig.2025.111956_bb0065","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1210\/en.2012-1065","article-title":"Ghrelin prevents incidence of malignant arrhythmia after acute myocardial infarction through vagal afferent nerves","volume":"153","author":"Mao","year":"2012","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.cellsig.2025.111956_bb0070","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00380-013-0333-2","article-title":"Ghrelin protects the heart against ischemia-induced arrhythmias by preserving connexin-43 protein","volume":"28","author":"Soeki","year":"2013","journal-title":"Heart Vessels"},{"issue":"1\u20132","key":"10.1016\/j.cellsig.2025.111956_bb0075","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000519330","article-title":"Impact of ghrelin on ventricular arrhythmia and related mechanism after myocardial infarction","volume":"107","author":"Hu","year":"2022","journal-title":"Pharmacology"},{"issue":"5","key":"10.1016\/j.cellsig.2025.111956_bb0080","doi-asserted-by":"crossref","first-page":"H2952","DOI":"10.1152\/ajpheart.00004.2007","article-title":"Hexarelin suppresses cardiac fibroblast proliferation and collagen synthesis in rat","volume":"293","author":"Xu","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"12","key":"10.1016\/j.cellsig.2025.111956_bb0085","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/hc3601.095575","article-title":"Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure","volume":"104","author":"Nagaya","year":"2001","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.cellsig.2025.111956_bb0090","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1210\/en.2003-0025","article-title":"The positive inotropic and calcium-mobilizing effects of growth hormone-releasing peptides on rat heart","volume":"144","author":"Xu","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.cellsig.2025.111956_bb0095","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad655.760","article-title":"Acyl ghrelin increases cardiac output and preserves right ventricular-pulmonary arterial coupling in patients with heart failure","volume":"44","author":"Erhardsson","year":"2023","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111956_bb0100","first-page":"H3020","article-title":"Cardiovascular effects of intravenous ghrelin infusion in healthy young men","volume":"293","author":"Vestergaard","year":"2007","journal-title":"Am. J. Physiol. C"},{"issue":"2\u20133","key":"10.1016\/j.cellsig.2025.111956_bb0105","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0014-2999(02)01934-9","article-title":"Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery","volume":"448","author":"Broglio","year":"2002","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.cellsig.2025.111956_bb0110","doi-asserted-by":"crossref","first-page":"5854","DOI":"10.1210\/jcem.86.12.8115","article-title":"Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure","volume":"86","author":"Nagaya","year":"2001","journal-title":"J. Clin. Endocr. Metab."},{"issue":"11","key":"10.1016\/j.cellsig.2025.111956_bb0115","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1210\/endo.141.11.7757","article-title":"Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans","volume":"141","author":"Date","year":"2000","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.cellsig.2025.111956_bb0125","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1210\/jc.2003-031964","article-title":"Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans","volume":"89","author":"Broglio","year":"2004","journal-title":"J. Clin. Endocr. Metab."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111956_bb0130","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/MCO.0000000000000390","article-title":"Ghrelin and autophagy","volume":"20","author":"Ezquerro","year":"2017","journal-title":"Curr. Opin. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111956_bb0135","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/jb\/mvw046","article-title":"Ghrelin O-acyltransferase (GOAT), a specific enzyme that modifies ghrelin with a medium-chain fatty acid","volume":"160","author":"Kojima","year":"2016","journal-title":"J. Biochem."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111956_bb0140","first-page":"3447","article-title":"Potential mechanisms of acyl-ghrelin in heart failure: insights into cholinergic modulation, Esc Heart Fail","volume":"11","author":"Hrabovska","year":"2024"},{"issue":"4","key":"10.1016\/j.cellsig.2025.111956_bb0145","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/cen.15196","article-title":"Ghrelin: an emerging therapy for heart failure","volume":"102","author":"Theodorakis","year":"2025","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"13","key":"10.1016\/j.cellsig.2025.111956_bb0150","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1073\/pnas.0305930101","article-title":"Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor","volume":"101","author":"Sun","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.cellsig.2025.111956_bb0155","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.peptides.2018.05.006","article-title":"Ghrelin and the heart","volume":"111","author":"Tokudome","year":"2019","journal-title":"Peptides"},{"key":"10.1016\/j.cellsig.2025.111956_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.614828","article-title":"Acylated ghrelin as a multi-targeted therapy for Alzheimer\u2019s and Parkinson\u2019s disease","volume":"14","author":"Reich","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.cellsig.2025.111956_bb0165","article-title":"A low-salt diet increases the expression of renal sirtuin 1 through activation of the ghrelin receptor in rats","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.cellsig.2025.111956_bb0170","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14323","article-title":"Unacylated ghrelin protects against age-related loss of muscle mass and contractile dysfunction in skeletal muscle","volume":"23","author":"Kim","year":"2024","journal-title":"Aging Cell"},{"issue":"6","key":"10.1016\/j.cellsig.2025.111956_bb0175","first-page":"G643","article-title":"Intestinal perfusion of unacylated ghrelin alleviated metabolically associated fatty liver disease in rats via a central glucagon-like peptide-1 pathway","volume":"326","author":"Lv","year":"2024","journal-title":"Am. J. Physiol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111956_bb0180","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00592-014-0637-4","article-title":"Protective effects of desacyl ghrelin on diabetic cardiomyopathy","volume":"52","author":"Pei","year":"2015","journal-title":"Acta Diabetol."},{"issue":"8","key":"10.1016\/j.cellsig.2025.111956_bb0185","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3390\/biology11081190","article-title":"Effect of ghrelin on the cardiovascular system","volume":"11","author":"Hosoda","year":"2022","journal-title":"Biology-Basel"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111956_bb0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.tem.2005.11.004","article-title":"Effects of ghrelin and synthetic GH secretagogues on the cardiovascular system","volume":"17","author":"Cao","year":"2006","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.cellsig.2025.111956_bb0195","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1385138","article-title":"Physiological effect of ghrelin on body systems","volume":"2020","author":"Akalu","year":"2020","journal-title":"Int. J. Endocrinol."},{"issue":"11","key":"10.1016\/j.cellsig.2025.111956_bb0200","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1002\/ejhf.3019","article-title":"Acyl ghrelin infusion increases circulating growth hormone in patients with heart failure and reduced ejection fraction","volume":"25","author":"Hage","year":"2023","journal-title":"Eur. J. Heart Fail."},{"issue":"22","key":"10.1016\/j.cellsig.2025.111956_bb0205","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1093\/eurheartj\/ehad100","article-title":"Acyl ghrelin improves cardiac function in heart failure and increases fractional shortening in cardiomyocytes without calcium mobilization","volume":"44","author":"Lund","year":"2023","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111956_bb0210","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00210-019-01664-9","article-title":"Acylated ghrelin prevents doxorubicin-induced cardiac intrinsic cell death and fibrosis in rats by restoring IL-6\/JAK2\/STAT3 signaling pathway and inhibition of STAT1","volume":"392","author":"Shati","year":"2019","journal-title":"N-S Arch. Pharmacol."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111956_bb0215","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cardiores.2004.01.024","article-title":"Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes","volume":"62","author":"Iglesias","year":"2004","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111956_bb0220","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1210\/jcem.87.6.8739","article-title":"The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans","volume":"87","author":"Gnanapavan","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111956_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126697","article-title":"Effect of ghrelin on mortality and cardiovascular outcomes in experimental rat and mice models of heart failure: a systematic review and meta-analysis","volume":"10","author":"Khatib","year":"2015","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.cellsig.2025.111956_bb0230","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.arcmed.2014.01.004","article-title":"Prognostic value of plasma ghrelin in predicting the outcome of patients with chronic heart failure","volume":"45","author":"Chen","year":"2014","journal-title":"Arch. Med. Res."},{"issue":"12","key":"10.1016\/j.cellsig.2025.111956_bb0235","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.peptides.2010.08.019","article-title":"Altered myocardial expression of ghrelin and its receptor (GHSR-1a) in patients with severe heart failure","volume":"31","author":"Beiras-Fernandez","year":"2010","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111956_bb0240","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20203387","article-title":"Research progress of ghrelin on cardiovascular disease","volume":"41","author":"Yuan","year":"2021","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111956_bb0245","doi-asserted-by":"crossref","first-page":"H426","DOI":"10.1152\/ajpheart.00643.2007","article-title":"Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction","volume":"294","author":"Soeki","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.cellsig.2025.111956_bb0250","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.biopha.2018.03.010","article-title":"Subacute ghrelin administration inhibits apoptosis and improves ultrastructural abnormalities in remote myocardium post-myocardial infarction","volume":"101","author":"Eid","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"22","key":"10.1016\/j.cellsig.2025.111956_bb0255","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1093\/eurheartj\/ehad220","article-title":"Acyl-ghrelin therapy for heart failure: already a novel inotrope or even more?","volume":"44","author":"Jankowska","year":"2023","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111956_bb0260","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ehf2.14580","article-title":"Acyl ghrelin increases cardiac output while preserving right ventricular-pulmonary arterial coupling in heart failure","volume":"11","author":"Erhardsson","year":"2024","journal-title":"Esc Heart Fail."},{"issue":"12","key":"10.1016\/j.cellsig.2025.111956_bb0265","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/hc3601.095575","article-title":"Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure","volume":"104","author":"Nagaya","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111956_bb0270","first-page":"H426","article-title":"Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction","volume":"294","author":"Soeki","year":"2008","journal-title":"Am. J. Physiol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111956_bb0275","doi-asserted-by":"crossref","DOI":"10.1007\/s00395-018-0671-4","article-title":"Cardioprotective effect of ghrelin against myocardial infarction-induced left ventricular injury via inhibition of SOCS3 and activation of JAK2\/STAT3 signaling","volume":"113","author":"Eid","year":"2018","journal-title":"Basic Res. Cardiol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111956_bb0280","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/13813455.2021.2017463","article-title":"Acylated ghrelin protection inhibits apoptosis in the remote myocardium post-myocardial infarction by inhibiting calcineurin and activating ARC","volume":"130","author":"Eid","year":"2024","journal-title":"Arch. Physiol. Biochem."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111956_bb0285","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1210\/en.2012-2132","article-title":"Excessive sympathoactivation and deteriorated heart function after myocardial infarction in male ghrelin knockout mice","volume":"154","author":"Mao","year":"2013","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111956_bb0290","doi-asserted-by":"crossref","DOI":"10.1186\/s13019-024-02994-3","article-title":"The protective effect of ghrelin peptide on doxorubicin hydrochloride induced heart failure in rats","volume":"19","author":"Peng","year":"2024","journal-title":"J. Cardiothorac. Surg."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111956_bb0295","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s12012-019-09527-8","article-title":"Acylated ghrelin protects the hearts of rats from doxorubicin-induced Fas\/FasL apoptosis by stimulating SERCA2a mediated by activation of PKA and Akt","volume":"19","author":"Shati","year":"2019","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.cellsig.2025.111956_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1402138","article-title":"Growth hormone releasing peptide-6 (GHRP-6) prevents doxorubicin-induced myocardial and extra-myocardial damages by activating prosurvival mechanisms","volume":"15","author":"Berlanga-Acosta","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111956_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043385","article-title":"Gut molecules in cardiometabolic diseases: the mechanisms behind the story","volume":"24","author":"Inceu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.cellsig.2025.111956_bb0310","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.2337\/dci22-0014","article-title":"Heart failure: an underappreciated complication of diabetes. A consensus report of the American Diabetes Association","volume":"45","author":"Pop-Busui","year":"2022","journal-title":"Diabet. Care"},{"key":"10.1016\/j.cellsig.2025.111956_bb0315","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.peptides.2017.12.015","article-title":"Ghrelin regulation of glucose metabolism","volume":"100","author":"Poher","year":"2018","journal-title":"Peptides"},{"issue":"7","key":"10.1016\/j.cellsig.2025.111956_bb0320","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12705","article-title":"Ghrelin regulation of glucose metabolism","volume":"31","author":"Gray","year":"2019","journal-title":"J. Neuroendocrinol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111956_bb0325","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2478\/jtim-2021-0025","article-title":"Effects of des-acyl ghrelin on insulin sensitivity and macrophage polarization in adipose tissue","volume":"9","author":"Yuan","year":"2021","journal-title":"J. Transl. Intern. Med."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111956_bb0330","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1530\/EJE-13-0072","article-title":"The pharmacokinetics of acyl, des-acyl, and total ghrelin in healthy human subjects","volume":"168","author":"Tong","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cellsig.2025.111956_bb0335","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.2147\/DMSO.S368770","article-title":"Relationship between acyl and Desacyl ghrelin levels with insulin resistance and body fat mass in type 2 diabetes mellitus","volume":"15","author":"Zang","year":"2022","journal-title":"Diabet. Metab. Synd. Obes."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111956_bb0340","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/1061186X.2023.2295268","article-title":"Ghrelin inhibits myocardial pyroptosis in diabetic cardiomyopathy by regulating ERS and NLRP3 inflammasome crosstalk through the PI3K\/AKT pathway","volume":"32","author":"Wang","year":"2024","journal-title":"J. Drug Target."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111956_bb0345","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1210\/en.2009-1432","article-title":"Effects of GH secretagogues on contractility and Ca2+ homeostasis of isolated adult rat ventricular myocytes","volume":"151","author":"Sun","year":"2010","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.cellsig.2025.111956_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035265","article-title":"Growth hormone secretagogues protect mouse cardiomyocytes from in vitro ischemia\/reperfusion injury through regulation of intracellular calcium","volume":"7","author":"Ma","year":"2012","journal-title":"PloS One"},{"issue":"18","key":"10.1016\/j.cellsig.2025.111956_bb0355","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/S0024-3205(01)01312-1","article-title":"Role of endothelial cells in modulation of contractility induced by hexarelin in rat ventricle","volume":"69","author":"Bedendi","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.cellsig.2025.111956_bb0360","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.peptides.2018.05.009","article-title":"Effect of the peptides Relaxin, Neuregulin, Ghrelin and Glucagon-like peptide-1, on cardiomyocyte factors involved in the molecular mechanisms leading to diastolic dysfunction and\/or heart failure with preserved ejection fraction","volume":"111","author":"Warbrick","year":"2019","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111956_bb0365","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cardiores.2004.12.022","article-title":"Regulation of cardiac contractile function by troponin I phosphorylation","volume":"66","author":"Layland","year":"2005","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111956_bb0370","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1210\/en.2009-0877","article-title":"Growth hormone secretagogues reduce transient outward K+ current via phospholipase C\/protein kinase C signaling pathway in rat ventricular myocytes","volume":"151","author":"Sun","year":"2010","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.cellsig.2025.111956_bb0375","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1210\/en.2012-1404","article-title":"Growth hormone secretagogues preserve the electrophysiological properties of mouse cardiomyocytes isolated from in vitro ischemia\/reperfusion heart","volume":"153","author":"Ma","year":"2012","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.cellsig.2025.111956_bb0380","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1161\/CIRCRESAHA.114.302589","article-title":"The autonomic nervous system and heart failure","volume":"114","author":"Florea","year":"2014","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.cellsig.2025.111956_bb0385","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1210\/en.2008-0472","article-title":"Early ghrelin treatment after myocardial infarction prevents an increase in cardiac sympathetic tone and reduces mortality","volume":"149","author":"Schwenke","year":"2008","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.cellsig.2025.111956_bb0390","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/FJC.0000000000001084","article-title":"Acylated ghrelin attenuates L-thyroxin-induced cardiac damage in rats by antioxidant and anti-inflammatory effects and downregulating components of the cardiac renin-angiotensin system","volume":"78","author":"Badi","year":"2021","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111956_bb0395","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/HYPERTENSIONAHA.114.04864","article-title":"Endogenous ghrelin attenuates pressure overload-induced cardiac hypertrophy via a cholinergic anti-inflammatory pathway","volume":"65","author":"Mao","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.cellsig.2025.111956_bb0400","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2017.00238","article-title":"Current understanding of the pathophysiology of myocardial fibrosis and its quantitative assessment in heart failure","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cellsig.2025.111956_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170446","article-title":"Ghrelin inhibited pressure overload-induced cardiac hypertrophy by promoting autophagy via CaMKK\/AMPK signaling pathway","volume":"136","author":"Lu","year":"2021","journal-title":"Peptides"},{"issue":"8","key":"10.1016\/j.cellsig.2025.111956_bb0410","first-page":"485","article-title":"Hexarelin protects cardiac H9C2 cells from angiotensin II-induced hypertrophy the regulation of autophagy","volume":"74","author":"Agbo","year":"2019","journal-title":"Pharmazie"},{"issue":"3","key":"10.1016\/j.cellsig.2025.111956_bb0415","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111956_bb0420","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1745-7254.2006.00319.x","article-title":"Cardioprotective effects of ghrelin and des-octanoyl ghrelin on myocardial injury induced by isoproterenol in rats","volume":"27","author":"Li","year":"2006","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111956_bb0425","first-page":"E311","article-title":"Desacyl ghrelin prevents doxorubicin-induced myocardial fibrosis and apoptosis via the GHSR-independent pathway","volume":"306","author":"Pei","year":"2014","journal-title":"Am. J. Physiol."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111956_bb0430","first-page":"H703","article-title":"Chronic administration of hexarelin attenuates cardiac fibrosis in the spontaneously hypertensive rat","volume":"303","author":"Xu","year":"2012","journal-title":"Am. J. Physiol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111956_bb0435","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.peptides.2010.11.011","article-title":"Ghrelin inhibits insulin resistance induced by glucotoxicity and lipotoxicity in cardiomyocyte","volume":"32","author":"Cao","year":"2011","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111956_bb0440","article-title":"Signaling pathways and targeted therapy for myocardial infarction","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Target"},{"key":"10.1016\/j.cellsig.2025.111956_bb0445","article-title":"Ghrelin ameliorates angiotensin II-induced myocardial fibrosis by upregulating peroxisome proliferator-activated receptor gamma in young male rats","volume":"2018","author":"Wang","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.cellsig.2025.111956_bb0450","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.freeradbiomed.2012.10.555","article-title":"Leonurine (SCM-198) attenuates myocardial fibrotic response via inhibition of NADPH oxidase 4","volume":"54","author":"Liu","year":"2013","journal-title":"Free Radical. Bio Med."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111956_bb0455","article-title":"Mechanisms of ghrelin anti-heart failure: inhibition of Ang II-induced cardiomyocyte apoptosis by down-regulating AT1R expression","volume":"9","author":"Yang","year":"2014","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.cellsig.2025.111956_bb0460","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/FJC.0b013e31824a7b60","article-title":"Ghrelin protects H9c2 cardiomyocytes from angiotensin II-induced apoptosis through the endoplasmic reticulum stress pathway","volume":"59","author":"Yang","year":"2012","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111956_bb0465","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.cellsig.2012.01.008","article-title":"Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling","volume":"24","author":"Ray","year":"2012","journal-title":"Cell. Signal."},{"key":"10.1016\/j.cellsig.2025.111956_bb0470","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.46.120604.141046","article-title":"Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway","volume":"47","author":"Kensler","year":"2007","journal-title":"Annu. Rev. Pharmacol."},{"key":"10.1016\/j.cellsig.2025.111956_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170613","article-title":"Ghrelin ameliorates cardiac fibrosis after myocardial infarction by regulating the Nrf2\/NADPH\/ROS pathway","volume":"144","author":"Wang","year":"2021","journal-title":"Peptides"},{"issue":"19","key":"10.1016\/j.cellsig.2025.111956_bb0480","doi-asserted-by":"crossref","DOI":"10.3390\/nu14194191","article-title":"Molecular mechanisms and health benefits of ghrelin: a narrative review","volume":"14","author":"Jiao","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.cellsig.2025.111956_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107281","article-title":"Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches","volume":"206","author":"Cai","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"24","key":"10.1016\/j.cellsig.2025.111956_bb0490","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417254","article-title":"Emerging relevance of ghrelin in programmed cell death and its application in diseases","volume":"24","author":"Zhang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111956_bb0495","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1083\/jcb.200207165","article-title":"Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1\/2 and PI 3-kinase\/AKT","volume":"159","author":"Baldanzi","year":"2002","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111956_bb0500","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bcp.2014.01.040","article-title":"Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK","volume":"88","author":"Wang","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111956_bb0505","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejphar.2010.12.011","article-title":"Ghrelin protects H9c2 cells from hydrogen peroxide-induced apoptosis through NF-\u03baB and mitochondria-mediated signaling","volume":"654","author":"Zhang","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.cellsig.2025.111956_bb0510","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tox.2008.02.018","article-title":"Ghrelin prevents doxorubicin-induced cardiotoxicity through TNF-alpha\/NF-\u03baB pathways and mitochondrial protective mechanisms","volume":"247","author":"Xu","year":"2008","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.cellsig.2025.111956_bb0515","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11033-017-4098-z","article-title":"Ghrelin protected neonatal rat cardiomyocyte against hypoxia\/reoxygenation injury by inhibiting apoptosis through Akt-mTOR signal","volume":"44","author":"Wang","year":"2017","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111956_bb0520","first-page":"2179","article-title":"Pretreatment of ghrelin protects H9c2 cells against hypoxia\/reoxygenation-induced cell death via PI3K\/AKT and AMPK pathways","volume":"47","author":"Chen","year":"2019","journal-title":"Artif.Cell Nanomed. B"},{"key":"10.1016\/j.cellsig.2025.111956_bb0525","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.peptides.2013.08.015","article-title":"Ghrelin protects heart against ERS-induced injury and apoptosis by activating AMP-activated protein kinase","volume":"48","author":"Zhang","year":"2013","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.cellsig.2025.111956_bb0530","first-page":"H1471","article-title":"Apelin-13 protects the heart against ischemia-reperfusion injury through inhibition of ER-dependent apoptotic pathways in a time-dependent fashion","volume":"301","author":"Tao","year":"2011","journal-title":"Am. J. Physiol."},{"issue":"21","key":"10.1016\/j.cellsig.2025.111956_bb0535","doi-asserted-by":"crossref","first-page":"9554","DOI":"10.1128\/MCB.25.21.9554-9575.2005","article-title":"AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress","volume":"25","author":"Terai","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cellsig.2025.111956_bb0540","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/130636","article-title":"AMP-activated protein kinase activation during cardioplegia-induced hypoxia\/reoxygenation injury attenuates cardiomyocytic apoptosis via reduction of endoplasmic reticulum stress","volume":"2010","author":"Yeh","year":"2010","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.cellsig.2025.111956_bb0545","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.12659\/MSM.908096","article-title":"Ghrelin alleviates angiotensin II-induced H9c2 apoptosis: impact of the miR-208 family","volume":"24","author":"Wang","year":"2018","journal-title":"Med. Sci. Monitor."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111956_bb0550","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.peptides.2012.06.020","article-title":"Ghrelin protects against cobalt chloride-induced hypoxic injury in cardiac H9c2 cells by inhibiting oxidative stress and inducing autophagy","volume":"38","author":"Tong","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.cellsig.2025.111956_bb0555","doi-asserted-by":"crossref","DOI":"10.1038\/srep15881","article-title":"The Akt-mTOR axis is a pivotal regulator of eccentric hypertrophy during volume overload","volume":"5","author":"Ikeda","year":"2015","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111956_bb0560","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/13813455.2018.1437751","article-title":"Ghrelin prevents cardiac cell apoptosis during cardiac remodelling post experimentally induced myocardial infarction in rats via activation of Raf-MEK1\/2-ERK1\/2 signalling","volume":"125","author":"Eid","year":"2019","journal-title":"Arch. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111956_bb0565","first-page":"H1643","article-title":"GH-releasing peptides improve cardiac dysfunction and cachexia and suppress stress-related hormones and cardiomyocyte apoptosis in rats with heart failure","volume":"289","author":"Xu","year":"2005","journal-title":"Am. J. Physiol."},{"issue":"10","key":"10.1016\/j.cellsig.2025.111956_bb0570","doi-asserted-by":"crossref","DOI":"10.31083\/j.rcm2510366","article-title":"Regulated cell death pathways in pathological cardiac hypertrophy","volume":"25","author":"Wu","year":"2024","journal-title":"Rev. Cardiovasc. Med."},{"issue":"18","key":"10.1016\/j.cellsig.2025.111956_bb0575","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810632","article-title":"NLRP3 inflammasome\/pyroptosis: a key driving force in diabetic cardiomyopathy","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2025.111956_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2022.153348","article-title":"Impaired autophagy and mitochondrial dynamics are involved in Sorafenib-induced cardiomyocyte apoptosis","volume":"481","author":"Liang","year":"2022","journal-title":"Toxicology"},{"issue":"5","key":"10.1016\/j.cellsig.2025.111956_bb0585","first-page":"402","article-title":"Ghrelin and autophagy","volume":"20","author":"Ezquerro","year":"2017","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.cellsig.2025.111956_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170264","article-title":"The new mechanism of Ghrelin\/GHSR-1a on autophagy regulation","volume":"126","author":"Yuan","year":"2020","journal-title":"Peptides"},{"issue":"11","key":"10.1016\/j.cellsig.2025.111956_bb0595","first-page":"239","article-title":"Ghrelin alleviates hypoxia\/reoxygenation-induced H9C2 injury by activating autophagy and AMPK\/ULK1 pathway","volume":"69","author":"Liu","year":"2023","journal-title":"Cell. Mol. Biol."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111956_bb0600","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/eje.0.1500447","article-title":"Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects","volume":"150","author":"Akamizu","year":"2004","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111956_bb0605","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.3390\/ijms15034837","article-title":"The growth hormone secretagogue receptor: its intracellular signaling and regulation","volume":"15","author":"Yin","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111956_bb0610","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.645","article-title":"Current developments of gene therapy in human diseases","volume":"5","author":"Liu","year":"2024","journal-title":"Medcomm"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825003717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825003717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T22:42:01Z","timestamp":1756248121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825003717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":121,"alternative-id":["S0898656825003717"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111956","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of ghrelin and synthetic GHS for heart failure from the perspective of its protective effect on cardiomyocytes","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111956","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111956"}}